Evidence map›Paper›PMID 39550311›Full record

ReviewThe Lancet. Digital health2025

Building robust, proportionate, and timely approaches to regulation and evaluation of digital mental health technologies.

Gareth Hopkin, Richard Branson, Paul Campbell, Holly Coole, Sophie Cooper, Francesca Edelmann, Grace Gatera, Jamie Morgan, Mark Salmon

Abstract readReview
In one paragraph

Review in The Lancet. Digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gareth HopkinNational Institute for Health and Care Excellence, Manchester, UK. Electronic address: gareth.hopkin@nice.org.uk.
Richard BransonMedicines and Healthcare products Regulatory Agency, London, UK.
Paul CampbellMedicines and Healthcare products Regulatory Agency, London, UK.
Holly CooleMedicines and Healthcare products Regulatory Agency, London, UK.
Sophie CooperNational Institute for Health and Care Excellence, Manchester, UK.
Francesca EdelmannMedicines and Healthcare products Regulatory Agency, London, UK.
Grace GateraWellcome Trust, London, UK.
Jamie MorganWellcome Trust, London, UK.
Mark SalmonNational Institute for Health and Care Excellence, Manchester, UK.

Funding

Wellcome Trust 226466
6 · The paper itself

Abstract

Demand for mental health services exceeds available resources globally, and access to diagnosis and evidence-based treatment is affected by long delays. Digital mental health technologies present an opportunity to reimagine the delivery of mental health support by providing innovative, effective, and tailored approaches that meet people's individual preferences and goals. These technologies also present new challenges, however, and efforts must be made to ensure they are safe and effective. The UK Medicines and Healthcare products Regulatory Agency and the National Institute for Health and Care Excellence have launched a partnership, funded by Wellcome, that explores regulation and evaluation of digital mental health technologies. This Viewpoint describes a series of key challenges across the regulatory and health technology assessment pathways and aims to facilitate discussions to ensure that approaches to regulation and evaluation are informed by patients, the public, and professionals working within mental health. We invite partners from across the mental health community to engage with, collaborate with, and provide scrutiny of this project to ensure it delivers the best possible outcomes.

Indexed as

Mental Health ServicesDigital TechnologyHumansMental HealthTechnology Assessment, BiomedicalUnited Kingdom

Identifiers

PMID39550311
PMCPMC7618730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.